Yair Schindel - Profile and Investment Details

Investor Profile

Yair Schindel is a Venture Capital, Founder, Angel Group, CEO, Investor based in Israel with a diverse investment portfolio that includes companies such as CuResponse, Karius, AbSci, CartiHeal, Zebra Medical Vision, Mammoth Biosciences, DayTwo, AtaCor Medical, MiNA Therapeutics, Ibex Medical Analytics, NanoGhosts, Theranica, Scipher Medicine, Seer, Mobilion Systems, Nobio, MAOZ מעוז, MDClone, Medial EarlySign, SOPHiA GENETICS, Vocalis Health, Viracta Therapeutics, Ayala Pharmaceuticals, Igentify, Nectin Therapeutics, Apos Therapy. Over time, Yair Schindel has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Yair Schindel is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Hospitals, Genetics, High-growth Startups, Alternative Medicine, Business Model Innovation, Digital Platforms, Strategic Partnerships, Life Science, Education, Artificial Intelligence (AI), Analytics, Business Development, Finance, Bioinformatics, Manufacturing, Biotechnology, Consumer Health, Electronic Health Records (EHR), Genomics, Health and Hospital Services, Personal Development, Consulting, Colleges, Health Diagnostics, Digital Health, Professional Networking, Medical, Big Data, Information Technology, B2B, Therapeutics, Machine Learning, Pharmaceuticals, Professional Development, Business Intelligence may find it worthwhile to explore potential connections with Yair Schindel, as their portfolio suggests a familiarity and interest in this area.

Understanding Yair Schindel’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.